Webcast on NSF (Nephrogenic Systemic Fibrosis)

8/14/2019 Webcast on NSF (Nephrogenic Systemic Fibrosis)

1/6


2/6

Nephrogenic systemic fibrosis (NSF) is a condition occurring in patients with kidney disease. While the disease i s not common,it may have debilitating manifestationsfor affected patients, and several patients have died as a result of complicationsassociatedwith NSF and comorbid conditions. Cases of NSF have been associatedwith patients with severe renal diseasereceiving gadolinium-based contrast agents (GBCAs)during magnetic resonance imaging (MRI). Cases of NSF have beenidentified in patients receiving all FDA-approved formulations of GBCAs.The FDA now requires a boxed warning andadditional new warnings regarding NSF on forms of GBCAs. As more NSF cases related to GBCAs are continually beingreported, there is concern and confusion on the part of imaging physiciansas to which patientsare affected and whatmust be done to prevent NSF and managelreport it when it occurs. Educationon this issue i s necessary and crucial.

The goal of this educational activity is to provide continuing educationto healthcare professionals with up-to-date information on NSF.FDUCAJIONAL OBJECCNFSFollowing this presentation,participants should be able to:1. ldentify the signs and symptoms of NSF and the patient populations at risk2. Explain the relationship between GBCAs and the developmentof NSF3. Differentiate the theories of causation for NSF post-GBCA administration4. Describe potential algorithms for changing imaging practice routines to better identify

patients at risk for NSF and to potentially prevent NSF5. ldentify the availableservices for reporting possible cases of NSF postcontrast administration


3/6

Radiologists, nephrologists, radiologic technologists, and other interestedphysicians, nurses, and allied health personnel.- l A a m l -

Stanley Coldfarb, MD, FACP, FASNProfessor of MedicineUniversity of Pennsylvania School of MedicinePhiladelphia, PA

Eric E. Williamson, M DAssistant Professor of RadiologyMayo Clinic College of MedicineRochester, MN

ACENDAEstimatedtime to complete this activity: 1 hour and 15 minutes

Welcome and lntrodcutionSection 1- Nephrogenicsystemic fibrosis (NSF)Section 2 - NSF and renal riskSection 3 - Contrast-enhancedmagnetic resonance imaging(MRI)and NSFSection 4 - Medical and regulatory response to gadolinium use and NSFQuestions andAnswersClosing Remarks

This archivedwebcast will be availableat: www.nsfwebcastO8.com from March 17, 2008 -September 17, 2008.

Questions?:Email us at jilli~an.chernyQinexelmsc.com r call (609) 219-8941


4/6

There is no fee for this educational activity.

Postgraduate lnstitute for Medicine designates this educationalactivity for a maximum of 1.25 AMA PRA Category ICredit(s)". Physicians should only claim credit commensuratewith the extent of their participation in the activity.

Accreditation StatementThis activity has been planned and implemented in accordancewith the EssentialAreas and Policies of the AccreditationCouncil for ContinuingMedical Education (ACCME) throughthe joint sponsorship of Postgraduate lnstitute for Medicine(PIM) and IneXel Medical Strategy & Communications. PIMis accredited by the ACCME to provide continuing medicaleducation for physicians.

ORNIA BOARDOF RFGlSIERFT) NUBSLNCPostgraduate lnstitute for Medicine i s approved by theCalifornia Board of Registered Nursing, Provider Number13485 for 1.5 contact hours.

NURSINGCONTINUING MFRICAI FWKAIIONColorado NursesAssociation/American NursesCreden ialing CenterThis educational activity for 1.25 contact hours is provided byPostgraduate lnstitute for Medicine (PIM).PIM i s an approved provider of continuing education by theColorado Nurses Association, an accredited approver by theAmerican Nurses Credentialing Center's CommissiononAccreditation.AS IU CONTINUING FDUCATIONApproved by the ASRT for CategoryAcontinuing education credit.DISCJOSIJRFOF CONFl ICTS OF INTFRFSTPostgraduate lnstitute or Medicine (PIM) requires instructors,planners, managers, and other individuals in a position to contrthe content of this activity to discloseany real or apparentconflict of interest they may have as related to the content of thisactivity. All identified conflicts of interest arethoroughly vetted bPIMfor fair balance, scientific objectivity of studies mentioned ithe materialsor used as the basis for content, and appropriatenessof patientcare recommendations.

JMebCa st..!nTm@ng Conundrum


5/6

and Inexel ~ e d i c a ltrategy% Communicat ions3:dpported through an educational grant from GE Healthcare - Medical Diagnostics


6/6

Documents

Webcast on NSF (Nephrogenic Systemic Fibrosis)